Suppr超能文献

二氢杨梅素改善低密度脂蛋白受体缺陷小鼠的动脉粥样硬化。

Dihydromyricetin ameliorates atherosclerosis in LDL receptor deficient mice.

作者信息

Liu Ting Ting, Zeng Yi, Tang Kun, Chen XueMeng, Zhang Wei, Xu Xiao Le

机构信息

Department of Pharmacology, Nantong University Pharmacy College, Nantong, China.

Department of Pharmacology, Nantong University Pharmacy College, Nantong, China.

出版信息

Atherosclerosis. 2017 Jul;262:39-50. doi: 10.1016/j.atherosclerosis.2017.05.003. Epub 2017 May 5.

Abstract

BACKGROUND AND AIMS

Dihydromyricetin, the most abundant flavonoid in Ampelopsis grossedentata, exerts numerous pharmacological activities, including anti-inflammatory, antioxidant, hepatoprotective, and lipid regulatory activities; however, its protective effect against atherosclerosis remains poorly understood. The aim of the present study was to evaluate the effects of dihydromyricetin on high fat diet (HFD)-induced atherosclerosis using LDL receptor deficient (LDLr) mice.

METHODS

Blood samples were collected for determination of serum lipid profiles, oxidized LDL (ox-LDL) and pro-inflammatory cytokines. Histology, hepatic lipid content, quantification of atherosclerosis, assessment of oxidative stress and inflammation were performed on liver and aorta samples by molecular biology methods. The effects of dihydromyricetin on ox-LDL-induced human umbilical vein endothelial cells (HUVECs) dysfunction and foam cell formation were further studied.

RESULTS

(1) Dihydromyricetin ameliorated hyperlipidemia, reduced serum ox-LDL, IL-6 and TNF-α levels in HFD-fed LDLr mice. Moreover, (2) dihydromyricetin suppressed hepatic lipid accumulation and increased protein expressions of PPARα, LXRα and ABCA1. (3) It inhibited atherosclerotic lesion formation and favoured features of plaque stability. (4) Dihydromyricetin prevented hepatic and aortic inflammation as evidenced by the reduced IL-6 and TNF-α mRNA expression; (5) it prevented hepatic and aortic oxidative stress by normalizing activities of antioxidant enzymes in the liver and suppressing reactive oxygen species generation and NOX2 protein expression in both liver and aorta; (6) it inhibited oxLDL-induced injury, monocytes adhesion and oxidative stress in HUVECs and (7) inhibited macrophage foam cell formation and enhanced cholesterol efflux.

CONCLUSIONS

These findings suggest that dihydromyricetin could reduce atherosclerosis via its pleiotropic effects, including improvement of endothelial dysfunction, inhibition of macrophage foam cell formation, amelioration of lipid profiles, anti-inflammatory action and anti-oxidative effect.

摘要

背景与目的

二氢杨梅素是显齿蛇葡萄中含量最为丰富的黄酮类化合物,具有多种药理活性,包括抗炎、抗氧化、保肝和脂质调节活性;然而,其对动脉粥样硬化的保护作用仍知之甚少。本研究旨在评估二氢杨梅素对高脂饮食(HFD)诱导的动脉粥样硬化的影响,实验使用低密度脂蛋白受体缺陷(LDLr)小鼠。

方法

采集血液样本以测定血脂谱、氧化型低密度脂蛋白(ox-LDL)和促炎细胞因子。通过分子生物学方法对肝脏和主动脉样本进行组织学、肝脏脂质含量、动脉粥样硬化定量、氧化应激和炎症评估。进一步研究二氢杨梅素对ox-LDL诱导的人脐静脉内皮细胞(HUVECs)功能障碍和泡沫细胞形成的影响。

结果

(1)二氢杨梅素改善了高脂饮食喂养的LDLr小鼠的高脂血症,降低了血清ox-LDL、白细胞介素-6(IL-6)和肿瘤坏死因子-α(TNF-α)水平。此外,(2)二氢杨梅素抑制肝脏脂质积累,并增加过氧化物酶体增殖物激活受体α(PPARα)、肝X受体α(LXRα)和ATP结合盒转运蛋白A1(ABCA1)的蛋白表达。(3)它抑制动脉粥样硬化病变形成,并有利于斑块稳定性特征。(4)二氢杨梅素可预防肝脏和主动脉炎症,白细胞介素-6和肿瘤坏死因子-α mRNA表达降低证明了这一点;(5)它通过使肝脏中抗氧化酶的活性正常化并抑制肝脏和主动脉中活性氧的产生以及NOX2蛋白表达,预防肝脏和主动脉氧化应激;(6)它抑制ox-LDL诱导的HUVECs损伤、单核细胞黏附和氧化应激,并且(7)抑制巨噬细胞泡沫细胞形成并增强胆固醇流出。

结论

这些发现表明,二氢杨梅素可通过其多效性作用减轻动脉粥样硬化,包括改善内皮功能障碍、抑制巨噬细胞泡沫细胞形成、改善血脂谱、抗炎作用和抗氧化作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验